These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9247098)

  • 1. Angiogenic and angiostatic microenvironment in tumors--role of gangliosides.
    Alessandri G; Cornaglia-Ferraris P; Gullino PM
    Acta Oncol; 1997; 36(4):383-7. PubMed ID: 9247098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
    Mirkin BL; Clark SH; Zhang C
    Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio.
    Ziche M; Morbidelli L; Alessandri G; Gullino PM
    Lab Invest; 1992 Dec; 67(6):711-5. PubMed ID: 1281244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium.
    Alessandri G; De Cristan G; Ziche M; Cappa AP; Gullino PM
    J Cell Physiol; 1992 Apr; 151(1):23-8. PubMed ID: 1560045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins and gangliosides of tumor microenvironment: their role in angiogenesis.
    Gullino PM
    Acta Oncol; 1995; 34(3):439-41. PubMed ID: 7540024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.
    Mukherjee P; Faber AC; Shelton LM; Baek RC; Chiles TC; Seyfried TN
    J Lipid Res; 2008 May; 49(5):929-38. PubMed ID: 18287616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
    Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R
    J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous gangliosides enhance the interaction of fibronectin with ganglioside-deficient cells.
    Yamada KM; Critchley DR; Fishman PH; Moss J
    Exp Cell Res; 1983 Feb; 143(2):295-302. PubMed ID: 6832218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells.
    Slevin M; Kumar S; He X; Gaffney J
    Int J Cancer; 1999 Jul; 82(3):412-23. PubMed ID: 10399959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin.
    Wang XQ; Sun P; Paller AS
    J Biol Chem; 2003 Jul; 278(28):25591-9. PubMed ID: 12724312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
    Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
    Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.
    Rusnati M; Tanghetti E; Urbinati C; Tulipano G; Marchesini S; Ziche M; Presta M
    Mol Biol Cell; 1999 Feb; 10(2):313-27. PubMed ID: 9950679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory action of ganglioside GM3 on murine neuroblastoma cell proliferation: modulating effect of fetal calf serum.
    Zhang C; Paller AS; Mirkin BL
    Anticancer Res; 1995; 15(3):661-6. PubMed ID: 7645939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen.
    Kleinman HK; Martin GR; Fishman PH
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3367-71. PubMed ID: 291010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides inhibit growth factor-stimulated neurite outgrowth in SH-SY5Y human neuroblastoma cells.
    Hynds DL; Burry RW; Yates AJ
    J Neurosci Res; 1997 Mar; 47(6):617-25. PubMed ID: 9089210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Neuro-2a neuroblastoma cells by an antibody to GM3 ganglioside.
    Chatterjee D; Chakraborty M; Anderson GM
    Brain Res; 1992 Jun; 583(1-2):31-44. PubMed ID: 1324094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anchored and soluble gangliosides contribute to myelosupportivity of stromal cells.
    Ziulkoski AL; dos Santos AX; Andrade CM; Trindade VM; Daniotti JL; Borojevic R; Guma FC
    Biochem Biophys Res Commun; 2009 Oct; 388(1):17-20. PubMed ID: 19632205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration.
    Lang Z; Guerrera M; Li R; Ladisch S
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1031-7. PubMed ID: 11352656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells.
    Inokuchi J; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
    J Cell Physiol; 1989 Dec; 141(3):573-83. PubMed ID: 2531751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.